KMT2A and acute myeloid leukemia: To determine the role of Vcam1 in AML progression in vivo, we next transduced tRFP657‐co‐expressing non‐targeting or Vcam1‐targeting sgRNAs into mouse MLL‐AF9/Cas9 cells and transplanted these cells into recipient mice (Fig 6I).